APA
Fervenza F. C., Canetta P. A., Barbour S. J., Lafayette R. A., Rovin B. H., Aslam N., Hladunewich M. A., Irazabal M. V., Sethi S., Gipson D. S., Reich H. N., Brenchley P., Kretzler M., Radhakrishnan J., Hebert L. A., Gipson P. E., Thomas L. F., McCarthy E. T., Appel G. B., Jefferson J. A., Eirin A., Lieske J. C., Hogan M. C., Greene E. L., Dillon J. J., Leung N., Sedor J. R., Rizk D. V., Blumenthal S. S., Lasic L. B., Juncos L. A., Green D. F., Simon J., Sussman A. N., Philibert D. & Cattran D. C. (20160502). A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). : Nephron.
Chicago
Fervenza Fernando C, Canetta Pietro A, Barbour Sean J, Lafayette Richard A, Rovin Brad H, Aslam Nabeel, Hladunewich Michelle A, Irazabal Maria V, Sethi Sanjeev, Gipson Debbie S, Reich Heather N, Brenchley Paul, Kretzler Matthias, Radhakrishnan Jai, Hebert Lee A, Gipson Patrick E, Thomas Leslie F, McCarthy Ellen T, Appel Gerald B, Jefferson J Ashley, Eirin Alfonso, Lieske John C, Hogan Marie C, Greene Eddie L, Dillon John J, Leung Nelson, Sedor John R, Rizk Dana V, Blumenthal Samuel S, Lasic Lada B, Juncos Luis A, Green Dollie F, Simon James, Sussman Amy N, Philibert David and Cattran Daniel C. 20160502. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). : Nephron.
Harvard
Fervenza F. C., Canetta P. A., Barbour S. J., Lafayette R. A., Rovin B. H., Aslam N., Hladunewich M. A., Irazabal M. V., Sethi S., Gipson D. S., Reich H. N., Brenchley P., Kretzler M., Radhakrishnan J., Hebert L. A., Gipson P. E., Thomas L. F., McCarthy E. T., Appel G. B., Jefferson J. A., Eirin A., Lieske J. C., Hogan M. C., Greene E. L., Dillon J. J., Leung N., Sedor J. R., Rizk D. V., Blumenthal S. S., Lasic L. B., Juncos L. A., Green D. F., Simon J., Sussman A. N., Philibert D. and Cattran D. C. (20160502). A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). : Nephron.
MLA
Fervenza Fernando C, Canetta Pietro A, Barbour Sean J, Lafayette Richard A, Rovin Brad H, Aslam Nabeel, Hladunewich Michelle A, Irazabal Maria V, Sethi Sanjeev, Gipson Debbie S, Reich Heather N, Brenchley Paul, Kretzler Matthias, Radhakrishnan Jai, Hebert Lee A, Gipson Patrick E, Thomas Leslie F, McCarthy Ellen T, Appel Gerald B, Jefferson J Ashley, Eirin Alfonso, Lieske John C, Hogan Marie C, Greene Eddie L, Dillon John J, Leung Nelson, Sedor John R, Rizk Dana V, Blumenthal Samuel S, Lasic Lada B, Juncos Luis A, Green Dollie F, Simon James, Sussman Amy N, Philibert David and Cattran Daniel C. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). : Nephron. 20160502.